Aptus Capital Advisors, LLC Ark Genomic Revolution ETF (De Transaction History
Aptus Capital Advisors, LLC
- $8.9 Billion
- Q4 2024
A detailed history of Aptus Capital Advisors, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 487 shares of ARKG stock, worth $10,728. This represents 0.0% of its overall portfolio holdings.
Number of Shares
487
Previous 520
6.35%
Holding current value
$10,728
Previous $13,000
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ARKG
# of Institutions
288Shares Held
23.4MCall Options Held
2.91MPut Options Held
2.5M-
Goldman Sachs Group Inc New York, NY3.63MShares$79.9 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.48MShares$76.8 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.79MShares$61.5 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.78MShares$61.3 Million0.01% of portfolio
-
Citigroup Inc1.66MShares$36.5 Million0.02% of portfolio